PL3837272T3 - Sposób sprzęgania biocząsteczek i zastosowanie donora złota do tworzenia kompleksów biocząsteczkowych - Google Patents

Sposób sprzęgania biocząsteczek i zastosowanie donora złota do tworzenia kompleksów biocząsteczkowych

Info

Publication number
PL3837272T3
PL3837272T3 PL18773251.6T PL18773251T PL3837272T3 PL 3837272 T3 PL3837272 T3 PL 3837272T3 PL 18773251 T PL18773251 T PL 18773251T PL 3837272 T3 PL3837272 T3 PL 3837272T3
Authority
PL
Poland
Prior art keywords
biomolecules
conjugation
complex formation
biomolecular complex
donor
Prior art date
Application number
PL18773251.6T
Other languages
English (en)
Inventor
Jonathan Heddle
Ali MALAY
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Publication of PL3837272T3 publication Critical patent/PL3837272T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18773251.6T 2018-08-16 2018-08-16 Sposób sprzęgania biocząsteczek i zastosowanie donora złota do tworzenia kompleksów biocząsteczkowych PL3837272T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/056150 WO2020035716A1 (en) 2018-08-16 2018-08-16 Method for conjugation of biomolecules and new use of gold donor for biomolecular complex formation

Publications (1)

Publication Number Publication Date
PL3837272T3 true PL3837272T3 (pl) 2025-06-23

Family

ID=63643014

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18773251.6T PL3837272T3 (pl) 2018-08-16 2018-08-16 Sposób sprzęgania biocząsteczek i zastosowanie donora złota do tworzenia kompleksów biocząsteczkowych

Country Status (9)

Country Link
US (1) US20210403503A1 (pl)
EP (1) EP3837272B1 (pl)
JP (1) JP7199512B2 (pl)
CN (1) CN112566919A (pl)
CA (1) CA3109328A1 (pl)
ES (1) ES3015690T3 (pl)
MX (1) MX2021001773A (pl)
PL (1) PL3837272T3 (pl)
WO (1) WO2020035716A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU102571B1 (en) * 2021-02-24 2022-08-24 Univ Jagiellonski An artificial protein-cage comprising encapsulated therein a guest cargo
LU102572B1 (en) * 2021-02-24 2022-08-24 Univ Jagiellonski An artificial protein-cage decorated with particular molecules on the exterior
LU102569B1 (en) * 2021-02-24 2022-08-24 Univ Jagiellonski An artificial trap-cage, its use and method of preparing thereof
WO2022182262A1 (en) * 2021-02-24 2022-09-01 Uniwersytet Jagielloński An artificial protein-cage comprising encapsulated therein a guest cargo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914588B2 (en) * 2007-04-10 2011-03-29 Los Alamos National Security, Llc Synthesis of fluorescent metal nanoclusters
EP3148554A1 (en) * 2014-05-28 2017-04-05 Auspherix Limited Gold (i)-phosphine compounds as anti-bacterial agents
CN105001244B (zh) * 2015-07-14 2017-12-15 山东大学 一种三唑金化合物及其制备方法与应用

Also Published As

Publication number Publication date
EP3837272A1 (en) 2021-06-23
ES3015690T3 (en) 2025-05-07
EP3837272C0 (en) 2025-02-26
JP7199512B2 (ja) 2023-01-05
MX2021001773A (es) 2021-04-19
CA3109328A1 (en) 2020-02-20
JP2021536431A (ja) 2021-12-27
US20210403503A1 (en) 2021-12-30
CN112566919A (zh) 2021-03-26
WO2020035716A1 (en) 2020-02-20
EP3837272B1 (en) 2025-02-26

Similar Documents

Publication Publication Date Title
IL290230A (en) Trivalent bispecific antibodies that bind to claudin 6 or claudin 18.2 and cd3 for the treatment of claudin-expressing cancers
IL279053A (en) Bispecific anti-PVRIG/ anti-TIGIT antibodies and methods of use
ZA201906757B (en) Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
IL278772A (en) Antibodies against 40-OX and methods of use
IL266918A (en) Anti-ctla-4 antibodies and methods of using them
ZA201902297B (en) Low-viscosity antigen binding proteins and methods of making them
SG11202000387YA (en) B7-h4 antibodies and methods of use thereof
SG10201913485QA (en) Chimeric antigen receptors based on single-domain antibodies and methods of use thereof
IL275070A (en) FCRN antibodies and methods of using them
GB202103867D0 (en) Claudin6 antibodies and methods of treating cancer
IL276790A (en) b7-h4 antibodies and methods of using them
PL3430054T3 (pl) Sposoby leczenia nowotworów z zastosowaniem antagonistów wiązania z osią PD-1 i przeciwciał anty-GPC3
PL3837272T3 (pl) Sposób sprzęgania biocząsteczek i zastosowanie donora złota do tworzenia kompleksów biocząsteczkowych
IL277212A (en) Anti-KLK5 antibodies and methods of use
IL281441B (en) Anti-cxcl13 antibodies for the treatment of autoimmune diseases and cancer
IL273538A (en) Anti-TRKB Monoclonal Antibodies and Methods of Use
EP3676294A4 (en) ANTI-CD3 ANTIBODIES AND METHOD OF MANUFACTURING AND USING THEREOF
IL279309A (en) Anti-BCMA CAR antibodies, conjugates and methods of use
SG11202003237QA (en) Bispecific antibodies and methods of making and using thereof
SG11202104518WA (en) Pharmaceutical combination of anti ceacam6 and tim3 antibodies